Search Results
Results found for "Neel Freedman"
- From Failed Experiments to Predictive GPCR Models
commercial compound libraries, the work inevitably reaches a point where novel, non-commercial ligands are needed
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
in mindset (seeing enzymes as predictable, targetable, quantifiable systems ) is exactly what teams need
- A2A Fluorescent Competitive Binding: Advancing NanoBRET® Target Engagement for GPCR Drug Discovery
They are needed to identify the best concentrations for each tool.
- Chemokine receptor-targeted drug discovery: progress and challenges
feature of the chemokine system (Nedjai et al. 2012), but more research in different cellular contexts is needed
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
opioid receptors were shown to constitutively activate Gi proteins in a membrane preparation without the need
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need
- New role of β-arrestins in MOR signaling
Opioids are analgesic drugs consumed non-medically for euphoric feelings and medically for pain relief
- đź“° GPCR Weekly News, May 6 to 12, 2024
Mark has experience connecting candidates with employers and will work with you to understand your needs
- Odorant receptors – a bit of smell for drug discovery
In order to target ectopic ORs there is a need to identify selective agonists or antagonists, where the
- Overview of adhesion GPCRs self-activation
complexes with Gs, Gi, Gq, and G12, where like other GPCRs, the distal αH5 region of the G protein was needed
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
Volpe et al. 2012); it dampens the inflammatory response when needed (C. A. H.
- Glyco-sulfo hotspots in the chemokine receptor system
Further research will be needed to boost our understanding on the dynamics and biological relevance of
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
low or temporary therapeutic effects.[3,4] Since dopaminergic signaling is very complex, there’s a need
- Ode to GPCRs
Much more need to be uncovered about bias signaling, tissue-specific GPCR activation profiles, compartmentalized
